|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/09 | (2006.01) |
| A61K 35/768 | (2015.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 37/04 | (2006.01) | ||
| C12N 7/01 | (2006.01) |
| (11) | Number of the document | 3480307 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17806608.0 |
| Date of filing the European patent application | 2017-05-29 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
| (46) | Date of publication of the claims translation | 2021-09-27 |
| (86) | Number | PCT/JP2017/019921 |
| Date | 2017-05-29 |
| (87) | Number | WO 2017/209053 |
| Date | 2017-12-07 |
| (30) | Number | Date | Country code |
| 2016107481 | 2016-05-30 | JP |
| (72) |
NAKAO, Shinsuke , JP
KAWASE, Tatsuya , JP
NAKAMURA, Takafumi , JP
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411,
JP
National University Corporation Tottori University , 101 Koyamacho-Minami 4-chome, Tottori-shi Tottori 680-8550, JP |
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Naujas genetiškai modifikuotas raupų virusas |
| NEW GENETICALLY-MODIFIED VACCINIA VIRUS |
| Payment date | Validity (years) | Amount | |
| 2024-05-03 | 8 | 185.00 EUR |
| 2025-05-29 |